Literature DB >> 7333013

A study of glycosaminoglycan excretion in normal and stone-forming subjects using a modified cetylpyridinium chloride technique.

C T Samuell.   

Abstract

Precipitation with cetylpyridinium chloride followed by hexuronic acid assay has been used to study glycosaminoglycan excretion in normal subjects and calcium stone formers. It was found necessary to concentrate dilute urines prior to assay to achieve satisfactory precipitation of the glycosaminoglycans. No significant differences in daily glycosaminoglycan excretion were detected between normal and stone-forming subjects.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7333013     DOI： 10.1016/0009-8981(81)90010-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


  6 in total

Review 1.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

2.  Investigation of GAGS on 24-hour and 2-hour urines from calcium oxalate stone formers and healthy subjects.

Authors:  M Gianotti; C Genestar; A Palou; A Pons; A Conte; F Grases
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

Review 3.  Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.

Authors:  R L Ryall
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

4.  Urinary glycosaminoglycan excretion in healthy and stone-forming children.

Authors:  F Harangi; Z Györke; B Melegh
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

5.  Pyrophosphate does not influence calcium oxalate or calcium phosphate crystal formation in concentrated whole human urine.

Authors:  P C Hallson; G A Rose; S Sulaiman
Journal:  Urol Res       Date:  1983

Review 6.  Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators.

Authors:  Kanu Priya Aggarwal; Shifa Narula; Monica Kakkar; Chanderdeep Tandon
Journal:  Biomed Res Int       Date:  2013-09-14       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.